Carol Lynn Brosgart - 04 Jun 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRM	Stock Option (right to buy)	Award	$0	+34,000		$0.000000	34,000	04 Jun 2021	Common Stock	34,000	$16.88	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant.